Suppr超能文献

通过 PIP2 调节小电导钙激活钾通道(SK2)的原子机制。

Atomistic mechanisms of the regulation of small-conductance Ca-activated K channel (SK2) by PIP2.

机构信息

Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, CA 95616.

Department of Physiology and Membrane Biology, University of California, Davis, CA 95616.

出版信息

Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2318900121. doi: 10.1073/pnas.2318900121. Epub 2024 Sep 17.

Abstract

Small-conductance Ca-activated K channels (SK, K2) are gated solely by intracellular microdomain Ca. The channel has emerged as a therapeutic target for cardiac arrhythmias. Calmodulin (CaM) interacts with the CaM binding domain (CaMBD) of the SK channels, serving as the obligatory Ca sensor to gate the channels. In heterologous expression systems, phosphatidylinositol 4,5-bisphosphate (PIP2) coordinates with CaM in regulating SK channels. However, the roles and mechanisms of PIP2 in regulating SK channels in cardiomyocytes remain unknown. Here, optogenetics, magnetic nanoparticles, combined with structural modeling, and molecular dynamics (MD) simulations revealed the atomistic mechanisms of how PIP2 works in concert with Ca-CaM in the SK channel activation. Our computational study affords evidence for the critical role of the amino acid residue R395 in the S6 transmembrane segment, which is localized in propinquity to the intracellular hydrophobic gate. This residue forms a salt bridge with residue E398 in the S6 transmembrane segment from the adjacent subunit. Both R395 and E398 are conserved in all known isoforms of SK channels. Our findings suggest that the binding of PIP2 to R395 residue disrupts the R395:E398 salt bridge, increasing the flexibility of the transmembrane segment S6 and the activation of the channel. Importantly, our findings serve as a platform for testing of structural-based drug designs for therapeutic inhibitors and activators of the SK channel family. The study is timely since inhibitors of SK channels are currently in clinical trials to treat atrial arrhythmias.

摘要

小电导钙激活钾通道(SK,K2)仅由细胞内微域 Ca 门控。该通道已成为心律失常的治疗靶点。钙调蛋白(CaM)与 SK 通道的钙调蛋白结合域(CaMBD)相互作用,作为门控通道的必需 Ca 传感器。在异源表达系统中,磷脂酰肌醇 4,5-二磷酸(PIP2)与 CaM 一起调节 SK 通道。然而,PIP2 在调节心肌细胞中的 SK 通道中的作用和机制尚不清楚。在这里,光遗传学、磁性纳米粒子与结构建模和分子动力学(MD)模拟相结合,揭示了 PIP2 与 Ca-CaM 协同作用激活 SK 通道的原子机制。我们的计算研究为氨基酸残基 R395 在 S6 跨膜片段中的关键作用提供了证据,该残基定位于细胞内疏水门附近。该残基与相邻亚基的 S6 跨膜片段中的残基 E398 形成盐桥。所有已知的 SK 通道同工型都保守 R395 和 E398。我们的发现表明,PIP2 与 R395 残基的结合破坏了 R395:E398 盐桥,增加了跨膜片段 S6 的灵活性和通道的激活。重要的是,我们的发现为 SK 通道家族的结构为基础的药物设计的抑制剂和激动剂的测试提供了一个平台。由于 SK 通道抑制剂目前正在临床试验中用于治疗心房心律失常,因此这项研究具有及时性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验